Announcing New Fourier 80 Benchtop FT-NMR Capabilities for Pharmaceutical and Food Analysis Markets
11 March 2022 - 1:40AM
Business Wire
Bruker Corporation (Nasdaq: BRKR) today announces new
capabilities for its benchtop Fourier transform (FT) nuclear
magnetic resonance (NMR) spectrometer, the Fourier 80, which does not require special
lab infrastructure or cryogens, and offers excellent 1H sensitivity
of 200:1 for gradient spectroscopy proton probes. A new adjustable
temperature option increases experimental flexibility, while new
solutions for pharma and food analysis provide improved synthesis
and process control, bringing NMR capabilities to more research and
analytical laboratories.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20220310005672/en/
Fourier 80 with an Adjustable Temperature
option (Photo: Business Wire)
The enhanced Fourier 80 now features an Adjustable
Temperature (AT) option, expanding its range of applications by
enabling sample analysis from 25°C up to 60°C, all compatible with
the optional Fourier 80 PAL sample changer.
The new Fourier 80 reaction monitoring solution RxnLab™
for chemical and pharmaceutical labs features
temperature-controlled reaction paths to minimize heat loss,
optimize process control, and monitor reaction products with the
new Fourier 80 flow accessory. Running InsightMR software,
the RxnLab brings benchtop FT-NMR to bio- and chemical
production with push-button operation for non-NMR experts. For
non-flow measurements, the Fourier RxnLab can also use standard 5
mm NMR tubes. The new Fourier 80 GxP Readiness Kit allows
full GxP compliance for development and manufacturing labs with 21
CFR part 11 compliance.
“We love the Fourier 80, it has been working 24/7 since it
arrived,” states Professor Andre Simpson from the University of
Toronto. “What sets it apart is its flexibility to run experiments
from our high field NMR systems, including all the pulse programs
we have written ourselves. The Fourier 80 revolutionizes what we
can do at low field and truly establishes it as a powerful research
tool.”
A new Fourier 80 food analysis solution, called NMR Olive Oil-Profiling™ 1.0, delivers
authenticity and quality analysis of olive oil, one of the most
adulterated food products worldwide. The new Olive Oil-Profiling
1.0 solution is suitable for olive oil bottlers, olive oil testing
laboratories, and satellite laboratories. Its companion high-field
400 MHz NMR FoodScreener supports private testing and
governmental laboratories in the analysis of multiple or complex
food matrices.
Dr. Venita Decker, Bruker’s Product Manager Compact NMR, stated:
“These new Fourier 80 capabilities and solutions push the
boundaries of benchtop FT-NMR. With the Adjustable Temperature
option, analytical chemists can now measure samples, e.g. at 25°C,
or 37°C one day, and polymers at 60°C the next. This is
particularly useful for reaction monitoring in chemical and
pharmaceutical research and QC.”
For more information, visit our Fourier 80 website.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries
and develop new applications that improve the quality of human
life. Bruker’s high performance scientific instruments and high
value analytical and diagnostic solutions enable scientists to
explore life and materials at molecular, cellular and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, improved productivity and customer success in life
science molecular and cell biology research, in applied and pharma
applications, in microscopy and nanoanalysis, as well as in
industrial applications. Bruker offers differentiated, high-value
life science and diagnostics systems and solutions in preclinical
imaging, clinical phenomics research, proteomics and multiomics,
spatial and single-cell biology, functional structural and
condensate biology, as well as in clinical microbiology and
molecular diagnostics. For more information, please visit:
www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220310005672/en/
Investor Contact: Justin Ward Sr. Director, Investor
Relations & Corporate Development T: +1 (978) 663-3660 x1479 E:
Investor.Relations@bruker.com
Media Contact: Thorsten Thiel, Ph. D. VP of Group
Marketing, Bruker BioSpin T: +49 (721) 5161–6500 E:
pr@bruker.com
Customer Contact: Dr. Venita Decker Product Manager
Compact NMR (TD/FT) Bruker BioSpin Group E:
compact.ftnmr@bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024